DNA Chip Research Inc logo

2397 - DNA Chip Research Inc Share Price

¥689 7.0  1.0%

Last Trade - 12:10am

Sector
Healthcare
Size
Micro Cap
Market Cap £26.3m
Enterprise Value £22.2m
Revenue £2.24m
Position in Universe 3314th / 3898
Bullish
Bearish
Unlock 2397 Revenue
Momentum
Relative Strength (%)
1m -9.87%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -40.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
357.3 284.2 324.6 362.8 360.8 361.7 +0.2%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 31 December 2020, DNA ChipResearch Inc revenues decreased 14% to Y162.4M. Net lossincreased 18% to Y179.4M. Revenues reflect Diagnosissegment decrease of 85% to Y4.6M. Higher net loss reflectsContract Research Business segment loss increase of 38% toY59.7M, Diagnosis segment loss increase of 32% to Y58.9M.Basic Earnings per Share excluding Extraordinary Itemsdecreased from -Y29.77 to -Y32.01.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

2397 Revenue Unlock 2397 Revenue

Net Income

2397 Net Income Unlock 2397 Revenue

Normalised EPS

2397 Normalised EPS Unlock 2397 Revenue

PE Ratio Range

2397 PE Ratio Range Unlock 2397 Revenue

Dividend Yield Range

2397 Dividend Yield Range Unlock 2397 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
2397 EPS Forecasts Unlock 2397 Revenue
Profile Summary

DNA Chip Research Inc. is primarily engaged in DNA chip-related analysis and next-generation sequence related technology research business, and diagnostic business which is engaged in the sales of medical-related equipment centered on EGFR-NGS Check. The Contract Research segment is engaged in the microarray, next-generation sequencing experiment analysis to universities and research institutes, pharmaceutical and food companies. The Diagnostic segemnt utilizes genetic analysis technology to disseminate tests corresponding to social needs on personalized medicine and undiseased society. The main menu of the diagnostic business is EGFR-NGS Check. The Research and Development segment includes research on cancer diagnosis technology using next generation sequencer, as well as the development of RNA check.

Directors
Last Annual March 31st, 2020
Last Interim December 31st, 2020
Incorporated April 1, 1999
Public Since March 18, 2004
No. of Shareholders: 4,880
No. of Employees: 32
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Tokyo Stock Exchange
Shares in Issue 5,789,563
Free Float (0.0%)
Eligible for
ISAs
SIPPs
2397 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 2397
Upcoming Events for 2397
Tuesday 30th March, 2021
Dividend For 2397.T - 0.0000 JPY
Frequently Asked Questions for DNA Chip Research Inc
What is the DNA Chip Research Inc share price?

As of 12:10am, shares in DNA Chip Research Inc are trading at ¥689, giving the company a market capitalisation of £26.3m. This share price information is delayed by 15 minutes.

How has the DNA Chip Research Inc share price performed this year?

Shares in DNA Chip Research Inc are currently trading at ¥689 and the price has moved by 8.43% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the DNA Chip Research Inc price has moved by -19.88% over the past year.

What are the analyst and broker recommendations for DNA Chip Research Inc?

Of the analysts with advisory recommendations for DNA Chip Research Inc, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for DNA Chip Research Inc is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will DNA Chip Research Inc next release its financial results?

DNA Chip Research Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the DNA Chip Research Inc dividend yield?

DNA Chip Research Inc does not currently pay a dividend.

Does DNA Chip Research Inc pay a dividend?

DNA Chip Research Inc does not currently pay a dividend.

When does DNA Chip Research Inc next pay dividends?

DNA Chip Research Inc does not currently pay a dividend.

How do I buy DNA Chip Research Inc shares?

To buy shares in DNA Chip Research Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of DNA Chip Research Inc?

Shares in DNA Chip Research Inc are currently trading at ¥689, giving the company a market capitalisation of £26.3m.

Where are DNA Chip Research Inc shares listed? Where are DNA Chip Research Inc shares listed?

Here are the trading details for DNA Chip Research Inc:

Country of listing: Japan
Exchange: TYO
Ticker Symbol: 2397
What kind of share is DNA Chip Research Inc?

Based on an overall assessment of its quality, value and momentum, DNA Chip Research Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a DNA Chip Research Inc share price forecast 2021?

We were not able to load any forecast data for DNA Chip Research Inc.

How can I tell whether the DNA Chip Research Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DNA Chip Research Inc. Over the past six months, the relative strength of its shares against the market has been -31.8%. At the current price of ¥689, shares in DNA Chip Research Inc are trading at -13.47% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the DNA Chip Research Inc PE Ratio?

We were not able to find PE ratio data for DNA Chip Research Inc.

Who are the key directors of DNA Chip Research Inc?

DNA Chip Research Inc's management team is headed by:

Ryo Matoba - PRE
Takuro Tamura - IND
Jun Yin Yim - OTH
Tokio Katayama - IND
Who are the major shareholders of DNA Chip Research Inc?

Here are the top five shareholders of DNA Chip Research Inc based on the size of their shareholding:

SBI Securities Co., Ltd. Research Firm
Percentage owned: 4.45% (258k shares)
Fujii (Mamoru) Individual Investor
Percentage owned: 4.36% (253k shares)
Kobashi (Ichita) Individual Investor
Percentage owned: 2.07% (120k shares)
Enplas Corp Corporation
Percentage owned: 1.71% (98.8k shares)
Edamatsu (Shichiro) Individual Investor
Percentage owned: 1.46% (84.4k shares)
Similar to 2397
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.